These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 355732)

  • 1. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
    Fleming CR; Ludwig J; Dickson ER
    Mayo Clin Proc; 1978 Sep; 53(9):587-93. PubMed ID: 355732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of penicillamine in advanced primary biliary cirrhosis.
    Dickson ER; Fleming TR; Wiesner RH; Baldus WP; Fleming CR; Ludwig J; McCall JT
    N Engl J Med; 1985 Apr; 312(16):1011-5. PubMed ID: 3885033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS; Alpert E; Resnick RH; Kaplan MM
    N Engl J Med; 1982 Feb; 306(6):319-26. PubMed ID: 7033789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.
    Deering TB; Dickson ER; Fleming CR; Geall MG; McCall JT; Baggenstoss AH
    Gastroenterology; 1977 Jun; 72(6):1208-12. PubMed ID: 870369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.
    Jain S; Scheuer PJ; Samourian S; McGee JO
    Lancet; 1977 Apr; 1(8016):831-4. PubMed ID: 67338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis.
    Bodenheimer HC; Schaffner F; Sternlieb I; Klion FM; Vernace S; Pezzullo J
    Hepatology; 1985; 5(6):1139-42. PubMed ID: 3905561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper stains and the syndrome of primary biliary cirrhosis. Evaluation of staining methods and their usefulness for diagnosis and trials of penicillamine treatment.
    Ludwig J; McDonald GS; Dickson ER; Elveback LR; McCall JT
    Arch Pathol Lab Med; 1979 Aug; 103(9):467-70. PubMed ID: 88927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.
    Neuberger J; Christensen E; Portmann B; Caballeria J; Rodes J; Ranek L; Tygstrup N; Williams R
    Gut; 1985 Feb; 26(2):114-9. PubMed ID: 3881323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The syndrome of primary biliary cirrhosis.
    Dickson ER
    J Rheumatol Suppl; 1981; 7():121-3. PubMed ID: 6939874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune associations in primary biliary cirrhosis.
    Culp KS; Fleming CR; Duffy J; Baldus WP; Dickson ER
    Mayo Clin Proc; 1982 Jun; 57(6):365-70. PubMed ID: 6896227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O; De Villiers D; Jain S; Potter BJ; Thomas HC; Sherlock S
    N Engl J Med; 1979 Feb; 300(6):274-8. PubMed ID: 759879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment.
    Salaspuro MP; Pikkarainen P; Sipponen P; Vuori E; Miettinen TA
    Gut; 1981 Nov; 22(11):901-6. PubMed ID: 7308845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis: D-Penicillamine vs. placebo/no intervention in patients with primary biliary cirrhosis--Cochrane Hepato-Biliary Group.
    Gong Y; Klingenberg SL; Gluud C
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1535-44. PubMed ID: 17206942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis.
    Seehafer JR; Rogers RS; Fleming CR; Dickson ER
    Arch Dermatol; 1981 Mar; 117(3):140-2. PubMed ID: 6452095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of histological progression in primary biliary cirrhosis.
    Locke GR; Therneau TM; Ludwig J; Dickson ER; Lindor KD
    Hepatology; 1996 Jan; 23(1):52-6. PubMed ID: 8550048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-penicillamine for primary biliary cirrhosis.
    Gong Y; Frederiksen SL; Gluud C
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004789. PubMed ID: 15495127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against D-penicillamine in primary biliary cirrhosis].
    Storch W
    Immun Infekt; 1990 Feb; 18(1):22-3. PubMed ID: 2179124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic copper accumulation in primary biliary cirrhosis.
    Benson GD
    Yale J Biol Med; 1979; 52(1):83-8. PubMed ID: 452626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.
    Taal BG; Schalm SW; Ten Kate FW; Van Berge Henegouwen GP; Brandt KH
    Liver; 1983 Dec; 3(6):345-52. PubMed ID: 6366419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.